[go: up one dir, main page]

WO2002069910A3 - Verwendung von substanzen, die verhindern, dass die no-synthase des warmblütigen organismus ihre wirkung entfaltet, zur herstellung von kosmetischen oder dermatologischen zubereitungen zur behandlung und/oder prophylaxe unerwünschter hautpigmentierung - Google Patents

Verwendung von substanzen, die verhindern, dass die no-synthase des warmblütigen organismus ihre wirkung entfaltet, zur herstellung von kosmetischen oder dermatologischen zubereitungen zur behandlung und/oder prophylaxe unerwünschter hautpigmentierung Download PDF

Info

Publication number
WO2002069910A3
WO2002069910A3 PCT/EP2002/002120 EP0202120W WO02069910A3 WO 2002069910 A3 WO2002069910 A3 WO 2002069910A3 EP 0202120 W EP0202120 W EP 0202120W WO 02069910 A3 WO02069910 A3 WO 02069910A3
Authority
WO
WIPO (PCT)
Prior art keywords
synthase
prophylaxis
warm
substances
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP2002/002120
Other languages
English (en)
French (fr)
Other versions
WO2002069910A2 (de
Inventor
Christopher Mummert
Claudia Mundt
Thomas Blatt
Ludger Kolbe
Rainer Wolber
Ernst Schaumann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beiersdorf AG
Original Assignee
Beiersdorf AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beiersdorf AG filed Critical Beiersdorf AG
Publication of WO2002069910A2 publication Critical patent/WO2002069910A2/de
Publication of WO2002069910A3 publication Critical patent/WO2002069910A3/de
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/31—Hydrocarbons
    • A61K8/315—Halogenated hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/35—Ketones, e.g. benzophenone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/43—Guanidines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
    • A61K8/463—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur containing sulfuric acid derivatives, e.g. sodium lauryl sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4913—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid
    • A61K8/492—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid having condensed rings, e.g. indol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4926—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63—Steroids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
    • A61K2800/782—Enzyme inhibitors; Enzyme antagonists

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Verwendung von Substanzen, die verhindern, daß die NO-Synthase des warmblütigen Organismus ihre Wirkung entfaltet, zur Herstellung kosmetischer oder dermatologischer Zubereitungen zur Behandlung und/oder Prophylaxe von Pigmentierungsstörungen.
PCT/EP2002/002120 2001-03-06 2002-02-28 Verwendung von substanzen, die verhindern, dass die no-synthase des warmblütigen organismus ihre wirkung entfaltet, zur herstellung von kosmetischen oder dermatologischen zubereitungen zur behandlung und/oder prophylaxe unerwünschter hautpigmentierung Ceased WO2002069910A2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10111050.2 2001-03-06
DE2001111050 DE10111050A1 (de) 2001-03-06 2001-03-06 Verwendung von Substanzen, die verhindern, daß die NO-Synthase des warmblütigenOrganismus ihre Wirkung entfaltet, zur Herstellung von kosmetischewn oder dermatologischen Zubereitungen zur Behandlung und/oder Prophylaxe unerwünschter Hautpigmentierung

Publications (2)

Publication Number Publication Date
WO2002069910A2 WO2002069910A2 (de) 2002-09-12
WO2002069910A3 true WO2002069910A3 (de) 2002-12-19

Family

ID=7676667

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2002/002120 Ceased WO2002069910A2 (de) 2001-03-06 2002-02-28 Verwendung von substanzen, die verhindern, dass die no-synthase des warmblütigen organismus ihre wirkung entfaltet, zur herstellung von kosmetischen oder dermatologischen zubereitungen zur behandlung und/oder prophylaxe unerwünschter hautpigmentierung

Country Status (2)

Country Link
DE (1) DE10111050A1 (de)
WO (1) WO2002069910A2 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10106133A1 (de) * 2001-02-10 2002-08-14 Beiersdorf Ag Kosmetische und dermatologische Lichtschutzformulierungen in Form von O/W-Emulsionen, mit einem Gehalt an Polyoxyethylen(20)cetylstearylether und hydrophoben anorganischen Mikropigmenten
DE102006028019A1 (de) * 2006-06-14 2007-12-20 Henkel Kgaa Aufhell- und/oder Färbemittel mit Acetamidinen
US8563552B2 (en) * 2008-02-08 2013-10-22 Shiseido Company Ltd. Whitening agent and skin external preparation
CN109820779A (zh) * 2019-02-25 2019-05-31 南阳市森源生物技术开发有限责任公司 一种祛斑霜及其制备方法

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996026711A1 (fr) * 1995-02-27 1996-09-06 L'oreal Inhibiteurs de no-synthase
WO1998011882A1 (en) * 1996-09-18 1998-03-26 Codon Pharmaceuticals, Inc. Pharmaceutical compositions and methods
EP1046392A2 (de) * 1999-04-24 2000-10-25 Beiersdorf AG Kosmetische und dermatologische Zubereitungen für die Verbesserung der Barrierefunktion
DE10000840A1 (de) * 2000-01-12 2001-07-19 Beiersdorf Ag Verwendung eines oder mehrerer NO-Synthasehemmer

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3620674A1 (de) * 1986-06-20 1987-12-23 Nattermann A & Cie Salbe zur behandlung von hauterkrankungen
US5449688A (en) * 1993-03-30 1995-09-12 The United States Of America As Represented By The Department Of Health And Human Services Method of treating chronic inflammatory diseases
GB9312204D0 (en) * 1993-06-14 1993-07-28 Zeneca Ltd Therapeutic composition
EP0729356A1 (de) * 1993-11-17 1996-09-04 Duke University Medical Center Verwendung von stickstoffoxid-synthase-inhibitoren zur behandlung von autoimmunerkrankungen
DE4341000A1 (de) * 1993-12-02 1995-06-08 Beiersdorf Ag Verwendung von L-Arginin, L-Ornithin oder L-Citrullin und topischen Zubereitungen mit diesen Stoffen
DE4341001A1 (de) * 1993-12-02 1995-06-08 Beiersdorf Ag Topische Zubereitungen mit einem Gehalt an L-Arginin
EP0957087B1 (de) * 1994-06-15 2002-12-04 The Wellcome Foundation Limited Zwischenprodukte verwendbar in der Herstellung von Enzym-Inhibitoren
BR9610375A (pt) * 1995-09-07 1999-07-06 Oreal Extrato de células composição cosmética ou farmacêutica utilização de pelo menos um extrato de células e processo de tratamento cosmético
ES2120274T3 (es) * 1995-09-07 1998-10-16 Oreal Utilizacion de un extracto de una bacteria filamentosa no fotosintetica y composicion.
FR2740339B1 (fr) * 1995-10-26 1997-12-05 Oreal Utilisation d'au moins un inhibiteur de no-synthase dans le traitement des peaux sensibles
FR2744915B1 (fr) * 1996-02-16 1998-03-27 Oreal Composition cosmetique a base de cellules indifferenciees de ginkgo biloba
FR2753098B1 (fr) * 1996-09-06 1998-11-27 Sod Conseils Rech Applic Composition pharmaceutique comprenant au moins un inhibiteur de no synthase et au moins un piegeur des formes reactives de l'oxygene
DE19711565A1 (de) * 1997-02-21 1998-08-27 Beiersdorf Ag Zubereitungen für die Behandlung von Rosacea
FR2764504B1 (fr) * 1997-06-11 2000-03-10 Oreal Utilisation d'un derive delipide de lait en tant qu'agent destine a freiner la chute des cheveux et/ou induire et stimuler leur croissance
DE19962267A1 (de) * 1999-12-23 2001-06-28 Beiersdorf Ag Verwendung von Wirkstoffkombinationen aus einem oder mehreren NO-Synthasehemmern und einer oder mehreren Ascorbylverbindungen zur Stärkung der Barrierefunktion der Haut

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996026711A1 (fr) * 1995-02-27 1996-09-06 L'oreal Inhibiteurs de no-synthase
WO1998011882A1 (en) * 1996-09-18 1998-03-26 Codon Pharmaceuticals, Inc. Pharmaceutical compositions and methods
EP1046392A2 (de) * 1999-04-24 2000-10-25 Beiersdorf AG Kosmetische und dermatologische Zubereitungen für die Verbesserung der Barrierefunktion
DE10000840A1 (de) * 2000-01-12 2001-07-19 Beiersdorf Ag Verwendung eines oder mehrerer NO-Synthasehemmer

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
KLIGMAN ET AL.: "A new formula for depigmenting human skin", ARCHIVES OF DERMATOLOGY, vol. 111, no. 1, January 1975 (1975-01-01), pages 40 - 48, XP002210190 *

Also Published As

Publication number Publication date
WO2002069910A2 (de) 2002-09-12
DE10111050A1 (de) 2002-09-12

Similar Documents

Publication Publication Date Title
WO2001085106A3 (de) Kosmetisches mittel enthaltend 2-furanonderivate
AU2001237433A1 (en) Preparation containing quinoxaline derivatives
WO2002049593A3 (de) Verwendung von dna-reparatur-enzymen als mmp-1-inhibitoren
WO2005102252A3 (de) Haut- und/oder haarmittel enthaltend verbindungen mit isoprenoider struktur
WO2003053383A3 (fr) Utilisation cosmetique d’au moins une hydrophobine pour le traitement des matieres keratiniques
AU2002233288A1 (en) Combined use of Enzyme Inhibitors and Pharmaceutical Preparations thereof for the Treatment and Prophylaxis of Arteriosclerosis, for the Treatment and Prevention of Allergic Reactions of Type I According to the Gell and Coombs Classification, and for the Treatment and Prevention of Dermatological Diseases Associated with FO
AU2003286567A1 (en) Methods for the treatment of skin disorders
WO2005020877A3 (de) Verwendung von biotin oder einem biotinderivat zur aufhellung der haut und behandlung von altersflecken
WO2002076494A3 (en) USE OF CYTOKINES OF THE TGF-β SUPERFAMILY FOR THE TREATMENT AND DIAGNOSIS OF SKIN RELATED DISORDERS
WO2002028810A3 (en) Retinoids for the treatment of emphysema
AU2001240940A1 (en) Cosmetic and dermatological composition for psoriatic skin, scalp treatment and care
WO2003015608A3 (en) Combination therapy for the treatment of cancer
WO2003088748A8 (en) Use of heme oxygenase-1 and products of heme degradation
EP1240891A3 (de) Mittel zum Färben von menschlichen Haaren
WO2006005455A3 (en) Amino, amino acid or peptide conjugates of retinoic acid
WO2002098347A3 (en) Methods and compositions that affect melanogenesis (pfi-016cip/pct)
EP1236465A3 (de) Verwendung von Gemüseprodukten zur Behandlung äusserer schädlicher Einflüsse
WO2002102340A3 (de) Verwendung von carnitin und/oder einem oder mehreren acyl-carnitinen zur herstellung von kosmetischen oder dermatologischen zubereitungen
AU2003210383A1 (en) Low ph, high skin friction cosmetic creams
WO2000049995A3 (de) Verwendung von mehrfach beschichteten glanzpigmenten zur farbgebung in kosmetischen pflegemitteln
WO2002069910A3 (de) Verwendung von substanzen, die verhindern, dass die no-synthase des warmblütigen organismus ihre wirkung entfaltet, zur herstellung von kosmetischen oder dermatologischen zubereitungen zur behandlung und/oder prophylaxe unerwünschter hautpigmentierung
WO2007034042A3 (fr) Extrait de vanilla planifolia, son procede d’obtention, et composition cosmetique ou dermatologique le contenant
WO2002098386A3 (de) Verwendung von natriumpolystyrolsulfonat zur hautstraffung
AU2002366530A1 (en) Utilization of dihydropinosylvin and derivatives thereof as tyrosinase inhibitors for skin lightening or as antimicrobial substances for preservation or for the treatment of acne, dandruff or body odors
AU2002330724A1 (en) Diagnosis, prevention and treatment of cancer

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): JP US

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): JP US

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP